Correlation Between Exxon and Neoleukin Therapeutics
Can any of the company-specific risk be diversified away by investing in both Exxon and Neoleukin Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Exxon and Neoleukin Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Exxon Mobil Corp and Neoleukin Therapeutics, you can compare the effects of market volatilities on Exxon and Neoleukin Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Exxon with a short position of Neoleukin Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Exxon and Neoleukin Therapeutics.
Diversification Opportunities for Exxon and Neoleukin Therapeutics
-0.61 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Exxon and Neoleukin is -0.61. Overlapping area represents the amount of risk that can be diversified away by holding Exxon Mobil Corp and Neoleukin Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neoleukin Therapeutics and Exxon is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Exxon Mobil Corp are associated (or correlated) with Neoleukin Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neoleukin Therapeutics has no effect on the direction of Exxon i.e., Exxon and Neoleukin Therapeutics go up and down completely randomly.
Pair Corralation between Exxon and Neoleukin Therapeutics
Considering the 90-day investment horizon Exxon Mobil Corp is expected to generate 0.29 times more return on investment than Neoleukin Therapeutics. However, Exxon Mobil Corp is 3.44 times less risky than Neoleukin Therapeutics. It trades about 0.05 of its potential returns per unit of risk. Neoleukin Therapeutics is currently generating about -0.08 per unit of risk. If you would invest 10,007 in Exxon Mobil Corp on August 27, 2024 and sell it today you would earn a total of 2,172 from holding Exxon Mobil Corp or generate 21.7% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 9.38% |
| Values | Daily Returns |
Exxon Mobil Corp vs. Neoleukin Therapeutics
Performance |
| Timeline |
| Exxon Mobil Corp |
| Neoleukin Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Exxon and Neoleukin Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Exxon and Neoleukin Therapeutics
The main advantage of trading using opposite Exxon and Neoleukin Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Exxon position performs unexpectedly, Neoleukin Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neoleukin Therapeutics will offset losses from the drop in Neoleukin Therapeutics' long position.The idea behind Exxon Mobil Corp and Neoleukin Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.| Neoleukin Therapeutics vs. CytomX Therapeutics | Neoleukin Therapeutics vs. Spero Therapeutics | Neoleukin Therapeutics vs. Instil Bio | Neoleukin Therapeutics vs. NextCure |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Other Complementary Tools
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |